Showing results (721-730 of 800) with videos related to
Sort By:
Pageof 80
The Annals of Thoracic Surgery|June 30, 2019
Incremental Risk of Annular Enlargement: A Multi-Institutional Cohort StudyRobert B Hawkins, Jared P Beller, J Hunter Mehaffey, et al.International Journal of Cancer|March 25, 2008
Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinomaVolker Ehemann, Michael A Kern, Marco Breinig, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2020
Role of mTOR As an Essential Kinase in SCLCJeffrey A Kern, Jihye Kim, Daniel G Foster, et al.Annals of Surgery|August 10, 2019
Meaningful Patient-centered Outcomes 1 Year Following Cardiac SurgeryEric J Charles, J Hunter Mehaffey, Robert B Hawkins, et al.The Journal of Thoracic and Cardiovascular Surgery|May 4, 2005
Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantationT Brett Reece, Peter I Ellman, Thomas S Maxey, et al.The Journal of Biological Chemistry|January 21, 2011
Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injuryJames H Finigan, Jihane A Faress, Emily Wilkinson, et al.The Journal of Clinical Endocrinology and Metabolism|November 9, 2006
Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammationVijayalakshmi Varma, Aiwei Yao-Borengasser, Neda Rasouli, et al.Annals of Surgery|June 15, 2006
Thoracic aortic endografting is the treatment of choice for elderly patients with thoracic aortic diseaseJohn A Kern, Alan H Matsumoto, Curtis G Tribble, et al.The Journal of Cell Biology|December 1, 1996
Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivoD Schadendorf, M A Kern, M Artuc, et al.Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trialJonathan D'Cunha, James E Herndon, Debra L Herzan, et al.Pageof 80